share_log

Baxter Expands Pharmaceuticals Portfolio With Five Injectable Products In U.S.

Benzinga ·  Apr 11 20:32
  • Five new launches reinforce Baxter's focus on differentiated products and enhance the company's Pharmaceuticals portfolio in critical therapeutic areas
  • Products feature ready-to-use formulations to help support patient safety and offer added convenience for healthcare professionals
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment